VEGFR2 inhibitors (Telik)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVEGFR2 inhibitors (Telik)
Drug Alias NameEAAFE2B8
ClassificationSmall molecules
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsAngiogenesis inhibitorsAnticancer protein kinase inhibitors
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics Holdings Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A